Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
01/2011
01/19/2011EP2275549A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
01/19/2011EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods
01/19/2011EP2275547A2 Polynucleotides and polypeptide sequences involved in the process of bonne remodeling
01/19/2011EP2275544A2 Genes and polypeptides relating to human colon cancers
01/19/2011EP2275541A2 Method for controlling the activity of immunologically functional molecule
01/19/2011EP2275540A2 Method for controlling the activity of immunologically functional molecule
01/19/2011EP2275537A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo
01/19/2011EP2275534A1 Novel strain of sars-associated coronavirus and applications thereof
01/19/2011EP2275450A1 Treatment with anti-ERBB2 antibodies
01/19/2011EP2275449A1 Antibodies that immunospecifically bind to blys
01/19/2011EP2275448A2 Monovalent antibody fragments useful as therapeutics
01/19/2011EP2275447A1 Methods of inhibiting metastasis
01/19/2011EP2275446A2 Antibodies to insulin-like growth factor I receptor
01/19/2011EP2275445A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
01/19/2011EP2275444A1 Chimeric anti CD44 antibodies and their use for treating acute myeloid leukemia
01/19/2011EP2275443A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
01/19/2011EP2275442A1 Detection and vizualization of the cell cycle in living cells
01/19/2011EP2275435A2 Streptococcus agalactiae antigens I + II
01/19/2011EP2275136A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
01/19/2011EP2275135A1 Therapeutic for hepatic cancer
01/19/2011EP2275134A2 Use of ADCC-optimized antibodies for treating weak patients
01/19/2011EP2275116A1 Use of a Pak inhibitor for the treatment of a joint disease
01/19/2011EP2274437A2 Compositions and methods for detecting egfr mutations in cancer
01/19/2011EP2274335A1 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes
01/19/2011EP2274334A2 Neutralizing molecules to viral antigens
01/19/2011EP2274333A2 Methods for treating psoriasis
01/19/2011EP2274332A1 Anti-tnf antibody
01/19/2011EP2274331A1 Improved fibronectin-based binding molecules and uses thereof
01/19/2011EP2274012A1 Cytotoxic immunoglobulin
01/19/2011EP2274011A2 An antibody bound synthetic vesicle containing active agent molecules
01/19/2011EP2274009A2 Methods of treatment
01/19/2011EP2274008A2 Compositions and methods for inhibiting pdgfrbeta and vegf-a
01/19/2011EP1773867B1 Proteinaceous compounds and uses therefor
01/19/2011EP1693456B1 Method of identifying modulators of a g protein-coupled receptor
01/19/2011EP1668036B1 Method for the production of human antibodies blocking the biological activity of a human cytokine
01/19/2011EP1556071B1 Methods to prevent tumor recurrence by blockade of tgf-beta
01/19/2011EP1548442B1 Method of diagnosing cancer by detecting gpc3
01/19/2011EP1411962B1 Monoclonal antibody therapy for pancreas cancer
01/19/2011EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
01/19/2011EP1185296B1 Prevention and treatment of amyloidogenic diseases
01/19/2011EP1132475B1 Novel serine protease bssp2
01/19/2011CN101952442A Transgenic plants modified for reduced cadmium transport, derivative products, and related methods
01/19/2011CN101952433A PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease
01/19/2011CN101952426A Anti-BST2 antibody
01/19/2011CN101952414A Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
01/19/2011CN101952319A Anti-mesothelin antibodies and uses therefor
01/19/2011CN101952318A Anti-NR10 antibody, and use thereof
01/19/2011CN101952317A Humanized anti-human NKG2A monoclonal antibody
01/19/2011CN101952316A Cadherin-11 ECl domain antagonists for treating inflammatory joint disorders
01/19/2011CN101952315A Agents targeting CD138 and uses thereof
01/19/2011CN101952314A Biokinetics of fast-clearing polypeptides
01/19/2011CN101952313A 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
01/19/2011CN101952312A Multispecific epitope binding proteins and uses thereof
01/19/2011CN101952311A G immunoglobulin used against anthrax toxins
01/19/2011CN101952310A Methods of inhibiting viral infection
01/19/2011CN101951955A Pharmaceutical composition for cancer treatment
01/19/2011CN101951954A Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6)
01/19/2011CN101951953A Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient
01/19/2011CN101951948A Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
01/19/2011CN101951885A Formulation
01/19/2011CN101949940A Detection kit of cow milk progesterone content
01/19/2011CN101949937A Time-resolved fluorescence (TRF) immunized detection kit of ovarian cancer tumor marker HE4
01/19/2011CN101949936A Colloidal gold test strip for detecting antibodies against akabane virus and preparation method thereof
01/19/2011CN101949935A HE4 (Human Epididymis Protein) monoclonal and polyclonal antibody preparation and development of corresponding diagnostic reagent kit
01/19/2011CN101949934A Early infection detection kit of monoclonal antibody-mediated pig pleuropneumoniae
01/19/2011CN101949925A Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method
01/19/2011CN101949921A Heavy metal enzyme label and application thereof
01/19/2011CN101948841A Epitope sequences
01/19/2011CN101948808A Antibody capable of resisting heavy metal mercury ions and application thereof
01/19/2011CN101948807A Heavy metal mercury ion antibody and application thereof
01/19/2011CN101948542A Nanoliposome antivenom active enzyme A2 and enteropathogen specific composite IgY and application thereof
01/19/2011CN101948541A Compositions and methods for the diagnosis and treatment of tumor
01/19/2011CN101948540A Preparation of novel anti-EGFR human source antibody MIL27 and application thereof
01/19/2011CN101948539A IL-18 binding proteins
01/19/2011CN101948538A Method for refining chicken egg yolk antibodies against Escherichia coli
01/19/2011CN101948537A Method for extracting chicken yolk antibody against infectious bursal disease
01/19/2011CN101948536A Porcine transmissible gastroenteritis virus (PTGEV) and porcine epidemic diarrhea virus (PEDV) dual yolk antibody and preparation method thereof
01/19/2011CN101948535A Method for separating immunoglobulin IgY from chicken blood
01/19/2011CN101948534A Method for screening antibodies
01/19/2011CN101948532A Naphthalene artificial immunogen NA-BSA and preparation method and application thereof
01/19/2011CN101948513A L27e family protein antigen epitope, antibody and application thereof
01/19/2011CN101948511A Papain antigenic epitope, antipain antibody and applications of papain antibody
01/18/2011US7872113 Nucleic acids encoding antibodies that bind interleukin-4 receptor
01/18/2011US7872110 Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
01/18/2011US7872106 Sclerostin-binding antibodies
01/18/2011US7872105 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits
01/18/2011US7872104 Antibody, immunoassay and method for prostate cancer detection
01/18/2011US7872103 Modulating immune responses
01/18/2011US7872102 Anti-IL-23 antibodies
01/18/2011US7871798 Mammalian cells that express VEGF-D polypeptides
01/18/2011US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents
01/18/2011US7871782 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy
01/18/2011US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications
01/18/2011US7871763 gene expression; probes, primers, antibodies
01/18/2011US7871622 Stably tethered structures of defined compositions with multiple functions or binding specificities
01/18/2011US7871621 Anti-HBs monoclonal antibody
01/18/2011US7871620 Immunoliposomes that optimize internationalization into target cells
01/18/2011US7871619 Using orphan receptors expressed on cell surfaces as screening tool in identifying modulating agents of cell proliferation; antitumor agents
01/18/2011US7871617 Von Willebrand's factor (VWC); transforming growth factors, bone morphongenic proteins as cofactors; monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure
01/18/2011US7871615 Humanized antibodies that recognize beta amyloid peptide